News
Biogen partners with Sage Therapeutics on depression, movement disorder drugs
Biogen entered into an agreement to jointly develop and commercialise Sage Therapeutics' zuranolone for major depressive disorder (MDD) and postpartum depression (PDD), as well...
News
AstraZeneca Says Forxiga Approved In Japan For Heart Failure
AstraZeneca’s Forxiga (dapagliflozin) has been approved in Japan for the treatment of patients with chronic heart failure (HF) who are receiving standard of care.
HF...
News
Lonza invests to expand manufacturing capabilities at Oregon site
Lonza AG has announced a significant investment to expand its particle engineering and drug product capabilities to meet increased market demand at its Bend,...
News
Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing with U.S. FDA for EUA
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that...
Drug Research
Moderna Announces Amendment to Current Supply Agreement with UK Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19
Moderna, Inc. , a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced...
News
Wasdell Group strengthens PPFL business with ISO 13485 for medical devices
The Wasdell Group, a leading outsourcing partner to companies in the pharmaceutical and biotech sector, has announced that its Dundalk, Ireland facility has been...
Press Releases
Bayer establishes Cell and Gene Therapy Platform to accelerate pharmaceutical innovation
Bayer AG announced the launch of a Cell and Gene Therapy (C>) Platform within its Pharmaceuticals division. Through this strategic platform, the company further...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read